secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elanco Animal Health Inc (ELAN)
CIK:        0001739104
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001104659-24-068253
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elanco shareholders approve board declassification, majority voting, and special meeting rights
--------------------------------------------------------------------------------

- Board declassified, majority vote standard adopted for uncontested director elections.
- Shareholders granted right to amend bylaws and request special meetings under certain conditions.
- Kathy Turner reappointed to 2025 class, Lawrence Kurzius to 2026 class to rebalance board terms.
- All four director nominees elected with votes ranging from 337M to 373M for.
- Auditor Ernst & Young ratified (454M for, 1.6M against); say-on-pay approved (409M for, 31M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739104/000110465924068253/0001104659-24-068253-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739104/000110465924068253/tm2416286d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-068253

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer